Market Closed -
OTC Markets
08:00:45 26/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.0134
USD
|
-49.24%
|
|
-88.33%
|
-51.62%
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
38.45
|
11.14
|
2.477
|
1.574
|
Enterprise Value (EV)
1 |
52.35
|
17
|
9.111
|
9.238
|
P/E ratio
|
-0.51
x
|
-0.21
x
|
-0.13
x
|
-0.72
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
3,73,28,827
x
|
22,96,851
x
|
1,88,63,123
x
|
EV / Revenue
|
-
|
5,69,91,803
x
|
84,47,911
x
|
11,07,31,129
x
|
EV / EBITDA
|
-
|
-22,41,606
x
|
-24,72,718
x
|
-
|
EV / FCF
|
70,95,363
x
|
-30,16,518
x
|
-7,95,513
x
|
-3,46,47,811
x
|
FCF Yield
|
0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
4.11
x
|
-1.3
x
|
-0.32
x
|
-0.16
x
|
Nbr of stocks (in thousands)
|
162
|
1,195
|
2,276
|
2,276
|
Reference price
2 |
237.1
|
9.315
|
1.088
|
0.6913
|
Announcement Date
|
28/01/20
|
29/01/21
|
05/10/22
|
17/04/23
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
0.2983
|
1.079
|
0.0834
|
EBITDA
|
-
|
-
|
-7.584
|
-3.685
|
-
|
EBIT
1 |
-0.9029
|
-24.42
|
-7.817
|
-3.752
|
-1.126
|
Operating Margin
|
-
|
-
|
-2,620.56%
|
-347.84%
|
-1,349.07%
|
Earnings before Tax (EBT)
1 |
-1.904
|
-54.22
|
-35.59
|
-16.71
|
-2.18
|
Net income
1 |
-1.904
|
-54.22
|
-35.59
|
-16.71
|
-2.18
|
Net margin
|
-
|
-
|
-11,930.2%
|
-1,549.76%
|
-2,612.62%
|
EPS
2 |
-108.2
|
-465.1
|
-44.11
|
-8.217
|
-0.9575
|
Free Cash Flow
|
-
|
7.379
|
-5.636
|
-11.45
|
-0.2666
|
FCF margin
|
-
|
-
|
-1,889.32%
|
-1,061.94%
|
-319.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/05/19
|
28/01/20
|
29/01/21
|
05/10/22
|
17/04/23
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
13.9
|
5.87
|
6.63
|
7.66
|
Net Cash position
1 |
0.76
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.7734
x
|
-1.8
x
|
-
|
Free Cash Flow
|
-
|
7.38
|
-5.64
|
-11.5
|
-0.27
|
ROE (net income / shareholders' equity)
|
-
|
-799%
|
-9,017%
|
206%
|
24.9%
|
ROA (Net income/ Total Assets)
|
-
|
-73.6%
|
-21.3%
|
-45.6%
|
-148%
|
Assets
1 |
-
|
73.65
|
167.3
|
36.62
|
1.477
|
Book Value Per Share
2 |
116.0
|
57.70
|
-7.170
|
-3.370
|
-4.330
|
Cash Flow per Share
2 |
20.80
|
0.7000
|
0.1600
|
0.0100
|
0.0100
|
Capex
|
-
|
0.06
|
0.08
|
-
|
-
|
Capex / Sales
|
-
|
-
|
27.03%
|
-
|
-
|
Announcement Date
|
31/05/19
|
28/01/20
|
29/01/21
|
05/10/22
|
17/04/23
|
|
1st Jan change
|
Capi.
|
---|
| -51.62% | 30.5T | | +26.93% | 554.75Cr | | -33.55% | 352.45Cr | | -3.74% | 302.93Cr | | -26.09% | 258.62Cr | | -10.93% | 228.39Cr | | +41.50% | 187.88Cr | | +41.84% | 145.94Cr | | -12.94% | 142.85Cr | | +47.62% | 142.21Cr |
Alternative Medicine
|